Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val J Lowe

Showing results (161-170 of 538) with videos related to

Pageof 54
Sort By:
Parkinsonism & Related Disorders|July 8, 2019
Multimodal neuroimaging relationships in progressive supranuclear palsyIrene Sintini, Christopher G Schwarz, Matthew L Senjem, et al.
Parkinsonism & Related Disorders|September 14, 2024
Prominent loss of striatal dopamine transporter binding in frontotemporal lobar degeneration with the MAPT N279K mutation present as early as at prodromal stage without parkinsonismToji Miyagawa, Cynthia Vernon, Scott A Przybelski, et al.
Neuroimage|June 6, 2022
Face recognition from research brain PET: An unexpected PET problemChristopher G Schwarz, Walter K Kremers, Val J Lowe, et al.
Journal of Neurology|October 22, 2025
Posterior cortical atrophy: reorganization of the dorsal attention network and its implications on volume loss and clinical performanceNeha Singh-Reilly, Jonathan Graff-Radford, Mary M Machulda, et al.
Journal of Neurology|April 5, 2024
A multimodal clinical diagnostic approach using MRI and <sup>18</sup>F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low-intermediate Alzheimer's disease neuropathologic changes and primary age-related tauopathyAnna Lavrova, Nha Trang Thu Pham, Cynthia J Vernon, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 24, 2021
P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET statusMichelle R Campbell, Susan Ashrafzadeh-Kian, Ronald C Petersen, et al.
The Journal of Urology|September 17, 2017
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using <sup>11</sup>C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance ImagingAvinash Nehra, William P Parker, Rimki Haloi, et al.
Nature Medicine|May 26, 2022
Performance of plasma phosphorylated tau 181 and 217 in the communityMichelle M Mielke, Jeffrey L Dage, Ryan D Frank, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 20, 2024
Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassaysDaniel J Figdore, Michael Griswold, Joshua A Bornhorst, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2024
Investigating the feasibility of <sup>18</sup>F-flortaucipir PET imaging in the antemortem diagnosis of primary age-related tauopathy (PART): An observational imaging-pathological studyAnna Lavrova, Ryota Satoh, Nha Trang Thu Pham, et al.
Pageof 54

Showing results (161-170 of 538) with videos related to

Sort By:
Pageof 54
Parkinsonism & Related Disorders|July 8, 2019
Multimodal neuroimaging relationships in progressive supranuclear palsyIrene Sintini, Christopher G Schwarz, Matthew L Senjem, et al.
Parkinsonism & Related Disorders|September 14, 2024
Prominent loss of striatal dopamine transporter binding in frontotemporal lobar degeneration with the MAPT N279K mutation present as early as at prodromal stage without parkinsonismToji Miyagawa, Cynthia Vernon, Scott A Przybelski, et al.
Neuroimage|June 6, 2022
Face recognition from research brain PET: An unexpected PET problemChristopher G Schwarz, Walter K Kremers, Val J Lowe, et al.
Journal of Neurology|October 22, 2025
Posterior cortical atrophy: reorganization of the dorsal attention network and its implications on volume loss and clinical performanceNeha Singh-Reilly, Jonathan Graff-Radford, Mary M Machulda, et al.
Journal of Neurology|April 5, 2024
A multimodal clinical diagnostic approach using MRI and <sup>18</sup>F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low-intermediate Alzheimer's disease neuropathologic changes and primary age-related tauopathyAnna Lavrova, Nha Trang Thu Pham, Cynthia J Vernon, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 24, 2021
P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET statusMichelle R Campbell, Susan Ashrafzadeh-Kian, Ronald C Petersen, et al.
The Journal of Urology|September 17, 2017
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using <sup>11</sup>C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance ImagingAvinash Nehra, William P Parker, Rimki Haloi, et al.
Nature Medicine|May 26, 2022
Performance of plasma phosphorylated tau 181 and 217 in the communityMichelle M Mielke, Jeffrey L Dage, Ryan D Frank, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 20, 2024
Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassaysDaniel J Figdore, Michael Griswold, Joshua A Bornhorst, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2024
Investigating the feasibility of <sup>18</sup>F-flortaucipir PET imaging in the antemortem diagnosis of primary age-related tauopathy (PART): An observational imaging-pathological studyAnna Lavrova, Ryota Satoh, Nha Trang Thu Pham, et al.
Pageof 54